Avior Wealth Management LLC increased its position in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 11.2% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 24,300 shares of the company’s stock after purchasing an additional 2,442 shares during the period. Avior Wealth Management LLC’s holdings in Option Care Health were worth $761,000 at the end of the most recent reporting period.
Other hedge funds have also bought and sold shares of the company. UMB Bank n.a. grew its stake in Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after acquiring an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its holdings in Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after acquiring an additional 1,446 shares during the last quarter. Blue Trust Inc. lifted its holdings in Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after acquiring an additional 377 shares during the last quarter. Finally, International Assets Investment Management LLC lifted its holdings in Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after acquiring an additional 2,757 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities analysts have issued reports on OPCH shares. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and cut their target price for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. JMP Securities raised their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. Barrington Research cut their target price on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. Finally, Truist Financial cut their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $30.83.
Insiders Place Their Bets
In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction dated Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.64% of the company’s stock.
Option Care Health Price Performance
Shares of NASDAQ:OPCH opened at $21.88 on Thursday. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.63. The stock has a market cap of $3.72 billion, a price-to-earnings ratio of 18.39, a PEG ratio of 2.27 and a beta of 1.32. The stock’s 50 day moving average price is $27.98 and its 200 day moving average price is $29.21. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
- Five stocks we like better than Option Care Health
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Roth IRA Calculator: Calculate Your Potential Returns
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 5 Dividend ETFs to Buy and Hold Forever
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.